Hepatic steatosis in the absence of tumor necrosis factor in mice

Cytokine

Volumn 32, Issue 6, 2005, Pages 287-295

  Schnyder Candrian, Silvia ^a,b   Czarniecki, Janusz ^c   Lerondel, Stephanie ^a   Corpataux, Josef ^b   Ryffel, Bernhard ^a   Schnyder, Bruno ^a,d  

^a CNRS   (France)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c Institute of Biopharmaceutical Research (IBR) Inc   (Switzerland)

^d Biomedical Research Foundation   (Switzerland)

Author keywords

Body mass; Cholesterol; Steatosis; Tibia length and density; TNF deficiency

Indexed keywords

INSULIN; LYMPHOTOXIN; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN KINASE B; SCAVENGER RECEPTOR BI; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FATTY ACID ANALYSIS; FATTY LIVER; HEPATOMEGALY; LIPID COMPOSITION; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WEIGHT GAIN; WILD TYPE;

ANIMALS; AORTA; CHOLESTEROL, DIETARY; CYCLIN D1; FATTY ACIDS; FATTY LIVER; HEPATOMEGALY; INSULIN; LIVER; LYMPHOTOXIN-ALPHA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; ORGAN SIZE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SCAVENGER RECEPTORS, CLASS B; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 31744446685     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2005.11.004     Document Type: Article

References (37)

1. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 2003 745 756
2. M. Feldmann, and R.N. Maini TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases Nat Med 9 2003 1245 1250
3. K.A. Papadakis, and S.R. Targan Tumor necrosis factor: biology and therapeutic inhibitors Gastroenterology 119 2000 1148 1157
4. D. Baeten, E. Kruithof, F. Van den Bosch, N. Van den Bossche, A. Herssens, and H. Mielants Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis 62 2003 829 834
5. O. Hultgren, H.P. Eugster, J.D. Sedgwick, H. Korner, and A. Tarkowski TNF/lymphotoxin-alpha double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus J Immunol 161 1998 5937 5942
6. H.P. Eugster, M. Muller, U. Karrer, B.D. Car, B. Schnyder, and V.M. Eng Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice Int Immunol 8 1996 23 36
7. T. Botha, and B. Ryffel Reactivation of latent tuberculosis infection in TNF-deficient mice J Immunol 171 2003 3110 3118
8. M.H. Weisman What are the risks of biologic therapy in rheumatoid arthritis? An update on safety J Rheumatol 65 Suppl 2002 33 38
9. T.U. Ciftci, O. Kokturk, N. Bukan, and A. Bilgihan The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Cytokine 28 2004 87 91
10. E. Cauza, K. Cauza, U. Hanusch-Enserer, M. Etemad, A. Dunky, and K. Kostner Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis Wien Klin Wochenschr 114 2002 1004 1007
11. S.A. Schreyer, J.J. Peschon, and R.C. LeBoeuf Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55 J Biol Chem 271 1996 26174 26178
12. S.A. Schreyer, C.M. Vick, and R.C. LeBoeuf Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice J Biol Chem 277 2002 12364 12368
13. H. Xu, J. Hirosumi, K.T. Uysal, A.D. Guler, and G.S. Hotamisligil Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance Endocrinology 143 2002 1502 1511
14. E. Nisoli, L. Briscini, A. Giordano, C. Tonello, S.M. Wiesbrock, and K.T. Uysal Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity Proc Natl Acad Sci U S A 97 2000 8033 8038
15. J.K. Sethi, and G.S. Hotamisligil The role of TNF alpha in adipocyte metabolism Semin Cell Dev Biol 10 1999 19 29
16. A. Beigneux, A.F. Hofmann, and S.G. Young Human CYP7A1 deficiency: progress and enigmas J Clin Invest 110 2002 29 31
17. M. Muller, H.P. Eugster, M. Le Hir, A. Shakhov, F. Di Padova, and C. Maurer Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation Mol Med 2 1996 247 255
18. M.W. Marino, A. Dunn, D. Grail, M. Inglese, Y. Noguchi, and E. Richards Characterization of tumor necrosis factor-deficient mice Proc Natl Acad Sci U S A 94 1997 8093 8098
19. M. Matsumoto, S. Mariathasan, M.H. Nahm, F. Baranyay, J.J. Peschon, and D.D. Chaplin Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers Science 271 1996 1289 1291
20. S.R. Ruuls, R.M. Hoek, V.N. Ngo, T. McNeil, L.A. Lucian, and M.J. Janatpour Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation Immunity 15 2001 533 543
21. B. Suter, K. Grob, B. Pacciarelli, and A. Novoselac Determination of fat content and fatty acid composition through 1-min transesterification in the food sample: II solubilization of fat, results Mitt Gebiete Lebensm Hyg 88 1997 259 276
22. B. Schnyder, M. Pittet, J. Durand, and S. Schnyder-Candrian Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport Am J Physiol Endocrinol Metab 282 2002 E87 E94
23. J.D. Browning, and J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
24. N. Fausto Liver regeneration J Hepatol 32 2000 19 31
25. T. Kudo, E. Nakayama, S. Suzuki, M. Akiyama, and S. Shibata Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver Am J Physiol Endocrinol Metab 287 2004 E644 E651
26. F.M. Gregoire, Q. Zhang, S.J. Smith, C. Tong, D. Ross, and H. Lopez Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice Am J Physiol Endocrinol Metab 282 2002 E703 E713
27. F. Hong, S. Radaeva, H.N. Pan, Z. Tian, R. Veech, and B. Gao Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease Hepatology 40 2004 933 941
28. T.L. Nelson, and M.S. Hickey Acute changes in dietary omega-3 fatty acid intake lowers soluble interleukin-6 receptor in healthy adult normal weight and overweight males Cytokine 26 2004 195 201
29. M. Ihrig, C.A. Dangler, and J.G. Fox Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas Atherosclerosis 156 2001 103 107
30. P. Neumeister, F.J. Pixley, Y. Xiong, H. Xie, K. Wu, and A. Ashton Cyclin d1 governs adhesion and motility of macrophages Mol Biol Cell 14 2003 2005 2015
31. S.A. Schreyer, S.C. Chua Jr., and R.C. LeBoeuf Obesity and diabetes in TNF-alpha receptor- deficient mice J Clin Invest 102 1998 402 411
32. K.T. Uysal, S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 1997 610 614
33. C. Buettner, R. Patel, E.D. Muse, S. Bhanot, B.P. Monia, and R. McKay Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice J Clin Invest 115 2005 1306 1313
34. H. Okamoto, S. Obici, D. Accili, and L. Rossetti Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action J Clin Invest 115 2005 1314 1322
35. Z. Li, S. Yang, H. Lin, J. Huang, P.A. Watkins, and A.B. Moser Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 2003 343 350
36. K.J. Tracey, H. Wei, K.R. Manogue, Y. Fong, D.G. Hesse, and H.T. Nguyen Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation J Exp Med 167 1988 1211 1227
37. A. Garg, and A. Misra Hepatic steatosis, insulin resistance, and adipose tissue disorders J Clin Endocrinol Metab 87 2002 3019 3022